Category: Include on Menu
-

Zenta Group Announces Strategic Shift Towards AI and Data Solutions Following ZentoAI Acquisition Agreement
Zenta Group Company Limited (NASDAQ:ZTG) has announced a board-approved strategic realignment aimed at shifting its business focus towards artificial intelligence and data solutions, following an agreement to acquire ZentoAI Intelligent Technology Company Limited. The Macau-based professional services company said the decision reflects changing market conditions and its intention to allocate more capital and management resources…
-

SkyWater Technology and D-Wave Quantum Extend Manufacturing Partnership to Advance Quantum Computing
SkyWater Technology (NASDAQ:SKYT) and D-Wave Quantum Inc. (NYSE:QBTS) have signed a new multi-year agreement extending their semiconductor manufacturing partnership, supporting the development and production of future generations of superconducting quantum computing technology. The agreement will continue manufacturing activities at SkyWater’s facility in Minnesota, building on a relationship between the two companies that has lasted more…
-

XTI Aerospace Completes Internal Review With No Financial Misstatements, Withdraws 2026 Guidance
XTI Aerospace, Inc. (NASDAQ:XTIA) has completed an internal review launched in July 2026, reporting that no financial misstatements were identified, while announcing the withdrawal of its previously issued full-year financial guidance. The Dallas-based aerospace and drone technology company expects to file its delayed quarterly report on Form 10-Q with the US Securities and Exchange Commission…
-

SentinelOne Shares Drop 7% After Announcing $1.25 Billion Convertible Notes Offering
SentinelOne (NYSE:S) shares declined 7% on Tuesday after the cybersecurity company announced plans to raise $1.25 billion through a private offering of convertible senior notes due in 2031. The proposed financing will be offered to qualified institutional buyers and is intended to provide additional capital for corporate purposes, potential acquisitions and a share repurchase programme.…
-

FB Financial Reports Third-Quarter EPS in Line With Estimates as Revenue Misses Forecasts
FB Financial Corporation (NYSE:FBK) reported third-quarter 2026 adjusted earnings per share of $1.21, matching analyst expectations, although revenue fell short of Wall Street forecasts. The Nashville-based bank holding company generated quarterly revenue of $174.49 million, below the consensus estimate of $181.55 million. Despite the revenue shortfall, the figure represented a 0.4% increase from $173.88 million…
-

DataMeds AI Announces Workforce Reductions as It Prioritises ChemoFx Cancer Diagnostic Test Commercialisation
DataMeds AI, Inc. (NASDAQ:MEDS) has announced cost-reduction measures, including cuts to corporate management positions, as the company redirects resources towards commercialising its ChemoFx diagnostic laboratory test for gynaecological cancers. The restructuring follows DataMeds AI’s acquisition of Helomics Corporation on 11 September 2026, which brought the ChemoFx testing platform and additional oncology research capabilities into the…
-

Ambry Genetics Launches Whole Genome Sequencing Tests to Improve Rare Disease Diagnosis
Ambry Genetics, a wholly owned subsidiary of Tempus AI (NASDAQ:TEM), has introduced GenomeNext and GenomeReveal, a new whole genome sequencing solution designed to improve the identification of genetic conditions in patients with rare diseases. The offering combines comprehensive DNA sequencing, RNA analysis and ongoing reassessment of genetic information to help identify disease-associated variants that may…
-

Developing Norra Kärr: Europe’s Answer to Chinese Heavy Rare Earth Elements Dominance
Leading Edge Materials CEO Kurt Budge discusses Norra Kärr’s 25-year mining lease, heavy rare earth potential and role in strengthening Europe’s critical mineral supply chain. Ricki: Europe currently produces no rare earths of its own, but one project in Sweden could potentially supply the continent with some of the hardest rare earth elements to source.…
-

Cognition Therapeutics Secures US Patent for Zervimesine Through 2045 Ahead of Planned Phase 3 Development
Cognition Therapeutics, Inc. (NASDAQ:CGTX) has received a new composition of matter patent from the US Patent and Trademark Office (USPTO) covering a crystalline form of its investigational drug candidate zervimesine (CT1812), extending intellectual property protection for the technology until 2045. The patent, numbered 12,759,979, covers a specific polymorphic crystalline form of zervimesine, a proprietary manufacturing…
-

SSR Mining Outlines 20-Year Marigold Mine Plan with Gold Reserves Rising 43% to 4.6 Million Ounces
SSR Mining Inc. (NASDAQ:SSRM) has published a new Technical Report Summary for its Marigold Gold Complex in Nevada, outlining a 20-year operating plan supported by an expanded mineral reserve base and the planned development of the neighbouring Buffalo Valley project. The updated assessment identifies 4.6 million ounces of gold mineral reserves at Marigold, representing a…